Review and update of the use of urokinase in the prevention and management of CVAD-related complications in pediatric oncology patients

American Journal of Infection Control

Volumn 36, Issue 1, 2008, Pages 54-58

  Simon, Arne ^a   Bode, Udo ^a   Lieber, Kerstin ^a   Beutel, Karin ^b   Fleischhack, Gudrun ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE;

ARTICLE; CANCER PATIENT; CATHETER INFECTION; CHILDHOOD CANCER; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EVIDENCE BASED PRACTICE; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

BLOOD COAGULATION; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHEMOPREVENTION; CHILD; CROSS INFECTION; GERMANY; HUMANS; NEOPLASMS; URINARY PLASMINOGEN ACTIVATOR;

EID: 38649116980     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2007.02.007     Document Type: Article

References (23)

1. Barnes C., Newall F., and Monagle P. Thromboembolic complications related to indwelling central venous catheters in children with oncological/haematological diseases: a retrospective study of 362 catheters. Support Care Cancer 10 (2002) 256-257 [author reply: 60-1]
2. Wilimas J.A., Hudson M., Rao B., Luo X., Lott L., and Kaste S.C. Late vascular occlusion of central lines in pediatric malignancies. Pediatrics 101 (1998) E7
3. Morrison V.A., Peterson B.A., and Bloomfield C.D. Nosocomial septicemia in the cancer patient: the influence of central venous access devices, neutropenia, and type of malignancy. Med Pediatr Oncol 18 (1990) 209-216
4. Simon A., Bode U., and Beutel K. Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Clin Microbiol Infect 12 (2006) 606-620
5. O'Grady N.P., Alexander M., Dellinger E.P., Gerberding J.L., Heard S.O., Maki D.G., et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 23 (2002) 759-769
6. Mermel L.A. Prevention of intravascular catheter-related infections. Ann Intern Med 132 (2000) 391-402
7. Raad I.I., Luna M., Khalil S.A., Costerton J.W., Lam C., and Bodey G.P. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 271 (1994) 1014-1016
8. Aquino V.M., Sandler E.S., Mustafa M.M., Steele J.W., and Buchanan G.R. A prospective double-blind randomized trial of urokinase flushes to prevent bacteremia resulting from luminal colonization of subcutaneous central venous catheters. J Pediatr Hematol Oncol 24 (2002) 710-713
9. Jones G.R., Konsler G.K., and Dunaway R.P. Urokinase in the treatment of bacteremia and candidemia in patients with right atrial catheters. Am J Infect Control 24 (1996) 160-166
10. Jones G.R., Konsler G.K., Dunaway R.P., Lacey S.R., and Azizkhan R.G. Prospective analysis of urokinase in the treatment of catheter sepsis in pediatric hematology-oncology patients. J Pediatr Surg 28 (1993) 350-355 [discussion: 5-7]
11. La Quaglia M.P., Caldwell C., Lucas A., Corbally M., Heller G., Steinherz L., et al. A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children. J Pediatr Surg 29 (1994) 742-745
12. Kellerman S., Chan J., and Jarvis W. Use of urokinase in pediatric hematology/oncology patients. Am J Infect Control 26 (1998) 502-506
13. Simon A., Beutel K., Hasan C., and Bode U. Evidence-based recommendation for the management of long-term central venous access devices in pediatric patients. 2nd ed. [in German] (2005), German Society of Pediatric Hematology and Oncology, Bonn
14. Solomon B., Moore J., Arthur C., and Prince H.M. Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomised comparison of urokinase versus heparin. Eur J Cancer 37 (2001) 2379-2384
15. Ray Jr. C.E., Shenoy S.S., McCarthy P.L., Broderick K.A., and Kaufman J.A. Weekly prophylactic urokinase instillation in tunneled central venous access devices. J Vasc Interv Radiol 10 (1999) 1330-1334
16. Kalmanti M., Germanakis J., Stiakaki E., Syfridaki C., Christidou A., Tsetis D., et al. Prophylaxis with urokinase in pediatric oncology patients with central venous catheters. Pediatr Hematol Oncol 19 (2002) 173-179
17. Dillon P.W., Jones G.R., Bagnall-Reeb H.A., Buckley J.D., Wiener E.S., and Haase G.M. Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study. J Clin Oncol 22 (2004) 2718-2723
18. Molinari A.C., Haupt R., Saracco P., Di Marco M., Castagnola E., and Fratino G. Urokinase for restoring patency of malfunctioning or blocked central venous catheters in children with hemato-oncological diseases. Support Care Cancer 12 (2004) 840-843
19. Bagnall H.A., Gomperts E., and Atkinson J.B. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children. Pediatrics 83 (1989) 963-966
20. Juve M.E. Intravenous catheter declotting: same outcomes with lower dose urokinase?. J Infus Nurs 26 (2003) 245-251
21. Svoboda P., Barton R.P., Barbarash O.L., Butylin A.A., Jacobs B.R., Lata J., et al. Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial. Crit Care Med 32 (2004) 1990-1996
22. Haire W.D., Deitcher S.R., Mullane K.M., Jaff M.R., Firszt C.M., Schulz G.A., et al. Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial. Thromb Haemost 92 (2004) 575-582
23. De Sio L., Jenkner A., Milano G.M., Ilari I., Fidani P., Castellano A., et al. Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients. Pediatr Infect Dis J 23 (2004) 963-965